Skip to main content
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
63.33
+0.38 (0.60%)
At close: Dec 5, 2025, 4:00 PM EST
64.25
+0.92 (1.45%)
After-hours: Dec 5, 2025, 7:55 PM EST

Halozyme Therapeutics Employees

Halozyme Therapeutics had 350 employees as of December 31, 2024. The number of employees decreased by 23 or -6.17% compared to the previous year.

Employees
350
Change (1Y)
-23
Growth (1Y)
-6.17%
Revenue / Employee
$3,551,006
Profits / Employee
$1,701,406
Market Cap
7.45B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2024350-23-6.17%
Dec 31, 2023373-20-5.09%
Dec 31, 2022393248171.03%
Dec 31, 202114596.62%
Dec 31, 202013643.03%
Dec 31, 2019132-149-53.02%
Dec 31, 20182812610.20%
Dec 31, 2017255-4-1.54%
Dec 31, 20162594319.91%
Dec 31, 20152166341.18%
Dec 31, 2014153-17-10.00%
Dec 31, 20131701811.84%
Dec 31, 20121521712.59%
Dec 31, 20111353332.35%
Dec 31, 2010102-38-27.14%
Dec 31, 2009140107.69%
Dec 31, 20081303841.30%
Dec 31, 20079252130.00%
Dec 31, 200640--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.

Related Stocks

Company Name Employees
UnitedHealth Group 400,000
Johnson & Johnson 138,100
Thermo Fisher Scientific 125,000
Abbott Laboratories 114,000
AstraZeneca 92,900
Novo Nordisk 77,349
Novartis AG 75,883
Merck & Co. 75,000
Employee Rankings

HALO News

More News